Jeffrey A. Stafford
Founder bij 858 Therapeutics, Inc.
Profiel
Jeffrey A.
Stafford is the President, Chief Executive Officer & Director of 858 Therapeutics, Inc. which he founded in 2019.
He is also the founder of Jecure Therapeutics, Inc. Dr. Stafford's former jobs include Director-Chemistry at GlaxoSmithKline, Inc., Vice President-Chemistry at Takeda San Diego, Inc. from 2002 to 2009, and Chief Scientific Officer at Quanticel Pharmaceuticals, Inc. Dr. Stafford received his undergraduate degree from the University of California, Los Angeles and his doctorate from Cornell University in 1989.
Actieve functies van Jeffrey A. Stafford
| Bedrijven | Functie | Begin |
|---|---|---|
858 Therapeutics, Inc.
 858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | Founder | 01-01-2019 |
Eerdere bekende functies van Jeffrey A. Stafford
| Bedrijven | Functie | Einde |
|---|---|---|
Jecure Therapeutics, Inc.
 Jecure Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jecure Therapeutics, Inc. provides therapeutic services for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. The company was founded by Ariel Feldstein in 2015 and is headquartered in San Diego, CA. | Chief Executive Officer | 01-05-2019 |
Takeda San Diego, Inc.
 Takeda San Diego, Inc. Medical DistributorsDistribution Services Takeda San Diego, Inc. discovers drugs for cancer treatment. It integrates protein crystallography and drug discovery technologies to generate Investigational New Drug (IND) candidates for the treatment of metabolic diseases and cancer. The company was founded in 1781 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01-01-2009 |
Quanticel Pharmaceuticals, Inc.
 Quanticel Pharmaceuticals, Inc. BiotechnologyHealth Technology Quanticel Pharmaceuticals, Inc. engaged in the development of medicines for the treatment of cancer. The company was founded by Stephen Quake and Michael Clarke in 2010 and was headquartered in San Francisco, CA. | Chief Tech/Sci/R&D Officer | - |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - |
Opleiding van Jeffrey A. Stafford
| University of California, Los Angeles | Undergraduate Degree |
| Cornell University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
Takeda San Diego, Inc.
Takeda San Diego, Inc. Medical DistributorsDistribution Services Takeda San Diego, Inc. discovers drugs for cancer treatment. It integrates protein crystallography and drug discovery technologies to generate Investigational New Drug (IND) candidates for the treatment of metabolic diseases and cancer. The company was founded in 1781 and is headquartered in San Diego, CA. | Distribution Services |
Quanticel Pharmaceuticals, Inc.
Quanticel Pharmaceuticals, Inc. BiotechnologyHealth Technology Quanticel Pharmaceuticals, Inc. engaged in the development of medicines for the treatment of cancer. The company was founded by Stephen Quake and Michael Clarke in 2010 and was headquartered in San Francisco, CA. | Health Technology |
Jecure Therapeutics, Inc.
Jecure Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jecure Therapeutics, Inc. provides therapeutic services for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. The company was founded by Ariel Feldstein in 2015 and is headquartered in San Diego, CA. | Commercial Services |
858 Therapeutics, Inc.
858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | Health Technology |
